Literature DB >> 10634676

Vasopressin: a therapeutic target in congestive heart failure?

S R Goldsmith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10634676     DOI： 10.1016/s1071-9164(99)91339-8

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  6 in total

Review 1.  Heart failure in 10 years time: focus on pharmacological treatment.

Authors:  J J V McMurray
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 2.  Significance of hyponatremia in heart failure.

Authors:  Luca Bettari; Mona Fiuzat; Gary M Felker; Christopher M O'Connor
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 3.  Vasopressin antagonists in heart failure.

Authors:  Ladan Golestaneh; Ashok Talreja; Thierry H Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2004-12

Review 4.  Hyponatremia in acute heart failure syndromes: a potential therapeutic target.

Authors:  Filippo Brandimarte; Francesco Fedele; Leonardo De Luca; Gregg C Fonarow; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2007-12

Review 5.  Treatment options for hyponatremia in heart failure.

Authors:  Steven R Goldsmith
Journal:  Heart Fail Rev       Date:  2008-09-06       Impact factor: 4.214

Review 6.  Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials.

Authors:  Jonathan Urbach; Steven R Goldsmith
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.